After Hours Mover 8/14: (JDSU) (ARNA) (PSX) Higher; (MYGN) (STSA) (INTC) Lower (more...)
Tweet Send to a FriendGet Alerts JDSU Hot Sheet
Down)
Trade JDSU Now!
After-hours movers:
JDS Uniphase Corp (NASDAQ: JDSU) 5% HIGHER; reported Q4 EPS of $0.15, $0.02 better than the analyst estimate of $0.13. Revenue for the quarter came in at $439.3 million versus the consensus estimate of $428.2 million. JDS Uniphase Corp sees Q1 2013 revenue of $415-435 million, versus the consensus of $427.06 million.
Myriad Genetics, Inc. (NASDAQ: MYGN) 4% LOWER; reported Q2 EPS of $0.34, in-line with the analyst estimate of $0.34. Revenue for the quarter came in at $133 million versus the consensus estimate of $131.85 million. Myriad Genetics, Inc. sees FY2012 EPS of $1.44-1.48, versus the consensus of $1.30. Myriad Genetics, Inc. sees FY2012 revenue of $550-565 million, versus the consensus of $494.50 million.
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) 4% HIGHER; continues today's 14% surge on takeover speculation
Sterling Financial Corp. (NASDAQ: STSA) 4% LOWER; stock offering
hillips 66 (NYSE: PSX) 2% HIGHER; Warren Buffett's Berkshire shows new stake
National Oilwell Varco, Inc. (NYSE: NOV) 1% HIGHER; Warren Buffett's Berkshire shows new stake
Aetna Inc. (NYSE: AET) 1% HIGHER; David Einhorn stake
Cheesecake Factory (Nasdaq: CAKE) 1% HIGHER; insider buy
Cobalt International Energy, Inc. (NYSE: CIE) 1% HIGHER; continues upside on positive analyst commentary
Intel Corporation (Nasdaq: INTC) 1% LOWER; Warren Buffett's Berkshire liquidates
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
JDS Uniphase Corp (NASDAQ: JDSU) 5% HIGHER; reported Q4 EPS of $0.15, $0.02 better than the analyst estimate of $0.13. Revenue for the quarter came in at $439.3 million versus the consensus estimate of $428.2 million. JDS Uniphase Corp sees Q1 2013 revenue of $415-435 million, versus the consensus of $427.06 million.
Myriad Genetics, Inc. (NASDAQ: MYGN) 4% LOWER; reported Q2 EPS of $0.34, in-line with the analyst estimate of $0.34. Revenue for the quarter came in at $133 million versus the consensus estimate of $131.85 million. Myriad Genetics, Inc. sees FY2012 EPS of $1.44-1.48, versus the consensus of $1.30. Myriad Genetics, Inc. sees FY2012 revenue of $550-565 million, versus the consensus of $494.50 million.
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) 4% HIGHER; continues today's 14% surge on takeover speculation
Sterling Financial Corp. (NASDAQ: STSA) 4% LOWER; stock offering
hillips 66 (NYSE: PSX) 2% HIGHER; Warren Buffett's Berkshire shows new stake
National Oilwell Varco, Inc. (NYSE: NOV) 1% HIGHER; Warren Buffett's Berkshire shows new stake
Aetna Inc. (NYSE: AET) 1% HIGHER; David Einhorn stake
Cheesecake Factory (Nasdaq: CAKE) 1% HIGHER; insider buy
Cobalt International Energy, Inc. (NYSE: CIE) 1% HIGHER; continues upside on positive analyst commentary
Intel Corporation (Nasdaq: INTC) 1% LOWER; Warren Buffett's Berkshire liquidates
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Berkshire Hathaway (BRK-A) Cut to 'AA' From 'AA+' by S&P
- Trading Radar for 05/17: Stage Stores (SSI), Donaldson (DCI) Report
- Notable Mergers and Acquisitions of the Day 05/17: (YHOO) (PRFT)
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Warren Buffett, Greenlight Capital, David Einhorn, After-Hours Movers
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
